A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults-Reference-Cited by-同舟云学术

A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults

Published:2017-08 Issue:8 Volume:39 Page:1695-1705
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Newcorn Jeffrey H.,Stark Jeffrey G.,Adcock Sherilyn,McMahen Russ,Sikes Carolyn

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Review of medication adherence in children and adults with ADHD;Adler;Postgrad Med,2010

2. ADHD & pharmacotherapy: past, present and future: a review of the changing landscape of drug therapy for attention deficit hyperactivity disorder;Connolly;Ther Innov Regul Sci,2015

3. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication;Kessler;Am J Psychiatry,2006

4. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review;Willcutt;Neurotherapeutics,2012

5. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents;Pediatrics,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Clinical Considerations in the Management of Adolescents with ADHD During Ramadan;Adolescent Psychiatry;2024-05-22

2. Alcohol-medication interactions: A systematic review and meta-analysis of placebo-controlled trials;Neuroscience & Biobehavioral Reviews;2022-01

3. Development of a Physiologically Based Pharmacokinetic Model for Prediction of Ethanol Concentration-Time Profile in Different Organs;Alcohol and Alcoholism;2020-12-15

4. Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions;CNS Spectrums;2020-02-26

5. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations;Expert Opinion on Drug Metabolism & Toxicology;2019-11-02